The “Final” 5-Year Follow-Up From the ENDEAVOR IV Trial Comparing a Zotarolimus-Eluting Stent With a Paclitaxel-Eluting Stent

201385 citationsJournal Article

Authors

Good health and well-being

Published in: JACC: Cardiovascular Interventions

Volume 6, Issue 4, pp. 325-333

Field-Weighted Citation Impact: 11.90